TNLIY yields 31.75% · JNJ yields 2.13%● Live data
📍 TNLIY pulled ahead of the other in Year 1
Combined, TNLIY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TNLIY + JNJ for your $10,000?
Trainline Plc operates an independent rail and coach travel platform that sells rail and coach tickets worldwide. The company operates through three segments: UK Consumer, UK Trainline Partner Solutions, and International. The UK Consumer segment provides travel apps and websites for individual travelers for journeys within the United Kingdom. The UK Trainline Partner Solutions segment offers travel portal platforms for corporates and travel management companies, and white label e-commerce platforms for train operating companies within the United Kingdom. The International segment provides travel apps and websites for individual travelers for journeys outside the United Kingdom. The company offers routes, fares, and journey times from 270 rail and coach carriers across 45 countries. Trainline Plc was founded in 1997 and is based in London, the United Kingdom.
Full TNLIY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.